Clinical Trial: "Stop Early Age-related Macular Degeneration (AMD) From Vision Loss Eternally" Study

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

Official Title: Focal Subthreshold Laser Treatment for Macular Drusen

Brief Summary: This study aims to validate the efficacy and safety of subthreshold laser photocoagulation on high-risk macular drusen in early age-related macular degeneration which has a high risk of conversion to exudative AMD.

Detailed Summary: SAVE Study (Stop Early Age-related Macular Degeneration form Vision Loss Eternally)
Sponsor: Seoul National University Bundang Hospital

Current Primary Outcome: Change in drusen size [ Time Frame: 3 month interval ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

  • Best Corrected Visual Acuity (BCVA) [ Time Frame: 3 months interval ]
    ETDRS and Snellen visual acuity measurement
  • Change in drusen distribution [ Time Frame: 3 month interval ]
  • Change in autofluorescence [ Time Frame: 3 month interval ]
  • Choroidal Neovascularization [ Time Frame: 3 months interval ]
  • Contrast Sensitivity [ Time Frame: 3 months interval ]
    Contrast Sensitivity Test


Original Secondary Outcome: Same as current

Information By: Seoul National University Bundang Hospital

Dates:
Date Received: June 30, 2016
Date Started: January 2016
Date Completion: June 2019
Last Updated: November 9, 2016
Last Verified: November 2016